SCHEMBL23309528

SCHEMBL23309528

CC(C)(C)Oc1ccc(NC(=O)c2cc(F)nc(F)c2F)cc1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PRSS12 P56730 1/20 0.44
▸ SCN8A Q9UQD0 1/20 0.43
▸ SCN10A Q9Y5Y9 1/20 0.43
▸ TRPV1 Q8NER1 4/20 0.43
▸ ABL1 P00519 6/20 0.42
▸ MEN1 O00255 4/20 0.41
▸ KMT2A Q03164 4/20 0.41
▸ HTT P42858 2/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ MAPT P10636 1/20 0.40
▸ NPC1 O15118 2/20 0.40
▸ CASP3 P42574 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ SENP7 Q9BQF6 1/20 0.40
▸ SENP6 Q9GZR1 1/20 0.40
▸ LMNA P02545 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ EPHX2 P34913 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23309707 0.89 ABL1 (0.54) TRPV1ABL1MEN1KMT2AHTT
SCHEMBL23309612 0.87 GRM4 (0.47) SCN8ASCN10ATRPV1HTTSMN1; SMN2
SCHEMBL23309617 0.86 NPC1 (0.54) MEN1KMT2ASMN1; SMN2MAPTNPC1
SCHEMBL23309730 0.85 KMT2A (0.47) MEN1KMT2AHTTSMN1; SMN2MAPT
SCHEMBL23309645 0.84 ALDH1A1 (0.51) TRPV1MEN1KMT2AHTTSMN1; SMN2
SCHEMBL23309514 0.83 TRPV1 (0.50) TRPV1MEN1KMT2AHTTSMN1; SMN2
SCHEMBL23309584 0.82 NPC1 (0.57) MEN1KMT2AHTTSMN1; SMN2MAPT
SCHEMBL23309621 0.81 RAB9A (0.50) MEN1KMT2AHTTSMN1; SMN2MAPT
SCHEMBL23309562 0.81 PNLIP (0.56) MEN1KMT2AHTTSMN1; SMN2MAPT
SCHEMBL23309490 0.78 GAA (0.51) MEN1KMT2AHTTSMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210120817-A1 PLANT DISEASE CONTROL AGENT MEIJI SEIKA PHARMA CO., LTD. (JP) 2021-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210120817-A1 PLANT DISEASE CONTROL AGENT BROX, ALG1, CTRL PRSS12 4311/4885SCN8A 2397/4885SCN10A 3170/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback